Related Experiment Video
Updated: Jan 18, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Transcription factors overcome the repressive impact of Polycomb-associated methylation in tumors
Abstract:
DNA methylation is a key epigenetic regulator often disrupted in cancer, yet how promoter methylation dynamics translate into transcriptional changes during cancer progression remains incompletely understood. Here, we employed targeted bisulfite sequencing and RNA-seq on paired tumor and non-tumor tissues from 80 Korean colorectal cancer (CRC) patients to map promoter methylation and gene expression dynamics. Promoters with high baseline methylation in non-tumor tissues tended to become hypomethylated in tumors, while those with low baseline methylation underwent partial hypermethylation. However, these changes did not consistently correlate with gene silencing or activation. Strikingly, promoters marked by Polycomb (PcG + ) in non-tumor tissue were prone to hypermethylation yet often remained transcriptionally active in tumors, a paradox most prominent in transcription factor (TF) genes. In contrast, hypermethylation in PcG - promoters was more consistently associated with transcriptional repression. Our findings suggest that epigenetic plasticity at PcG + TF gene promoters can override the typically repressive effects of DNA methylation, potentially enabling tumors to maintain or enhance the expression of key regulatory genes. This highlights the importance of PcG occupancy in shaping the functional consequences of methylation changes during colorectal tumorigenesis, warranting deeper investigation into how these epigenetic adaptations drive cancer progression.
Insights
DNA methylation changes in colorectal cancer (CRC) don't always silence genes. Polycomb-marked genes can remain active despite DNA hypermethylation, suggesting epigenetic plasticity drives cancer progression.
Area of Science:
- Epigenetics and Genomics
- Cancer Biology
- Molecular Oncology
Background:
- DNA methylation is a crucial epigenetic mechanism frequently altered in cancer.
- Understanding how DNA methylation dynamics influence gene expression during cancer progression is essential.
- Colorectal cancer (CRC) exhibits significant epigenetic dysregulation.
Purpose of the Study:
- To investigate the relationship between DNA methylation patterns and gene expression in colorectal cancer.
- To map promoter methylation and gene expression dynamics in paired tumor and non-tumor tissues.
- To elucidate the role of Polycomb group (PcG) occupancy in mediating methylation-driven transcriptional changes.
Main Methods:
- Targeted bisulfite sequencing to analyze DNA methylation.
- RNA sequencing (RNA-seq) to assess gene expression levels.
- Analysis of paired tumor and non-tumor tissues from 80 Korean colorectal cancer patients.
Main Results:
- Promoter methylation patterns showed dynamic shifts between non-tumor and tumor tissues.
- Changes in DNA methylation did not consistently correlate with gene silencing or activation.
- Polycomb-marked (PcG+) promoters were prone to hypermethylation but often retained transcriptional activity in tumors, particularly for transcription factor (TF) genes.
- Hypermethylation in non-PcG-marked (PcG-) promoters was more consistently linked to transcriptional repression.
Conclusions:
- Epigenetic plasticity at PcG+ TF gene promoters can overcome the repressive effects of DNA methylation in colorectal cancer.
- Tumors may leverage this plasticity to maintain or enhance the expression of key regulatory genes.
- PcG occupancy is critical in determining the functional impact of DNA methylation changes during colorectal tumorigenesis.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Co-activators and Co-repressors
Co-activators and Co-repressors

